To further assess the importance of changes in canonical NFκB signaling with regard to the anti-cancer effects of ERβ, we determined the impact of p65 knockdown (Fig. 2e, f) and constitutive activation (Fig. 2g, h) on ERβ+ cell proliferation. Here, NFKB1 is linked to cancer.